Antioxidants in critically ill patients;Place des anti-oxydants dans la nutrition du patient septique

Reanimation

Volumn 11, Issue 6, 2002, Pages 411-420

  Fontaine, E ^a   Barnoud, D ^a   Schwebel, C ^a   Leverve, X ^a  

^a HÔPITAL MICHALLON   (France)

Author keywords

Antioxidant; ARDS; Critically ill; Oxidative stress; ROS; Septis

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ALLOPURINOL; ALPHA TOCOPHEROL; ASCORBIC ACID; BILIRUBIN; CYSTEINE; DEFEROXAMINE; MEPREDNISONE; NITRONE DERIVATIVE; PHENYLBUTYLNITRONE; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UBIDECARENONE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; CRITICAL ILLNESS; EVIDENCE BASED MEDICINE; HUMAN; INTENSIVE CARE; METABOLIC DISORDER; OXIDATIVE STRESS; PATHOLOGICAL ANATOMY; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036758156     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1624-0693(02)00269-4     Document Type: Short Survey

References (80)

1. Gutteridge JM. Free radicals in disease processes: A compilation of cause and consequence. Free Radic Res Commun 1993; 19: 141-58.
2. Novelli GP. Role of free radicals in septic shock. J Physiol Pharmacol 1997; 48: 517-27.
3. Oldham KM, Bowen PE. Oxidative stress in critical care: Is antioxidant supplementation beneficial? J Am Diet Assoc 1998; 98: 1001-8.
4. Goode HF, Webster NR. Free radicals and antioxidants in sepsis. Crit Care Med 1993; 21: 1770-6.
5. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence? Lancet 1994; 344: 721-4.
6. Buettner GR, Jurkiewicz BA. Catalytic metals, ascorbate and free radicals: Combinations to avoid. Radiat Res 1996; 145: 532-41.
7. Herbert V, Shaw S, Jayatilleke E. VitaminC-driven free radical generation from iron. J Nutr 1996; 126 (Suppl 4):1213S-20S.
8. Takeda K, Shimada Y, Amano M, Sakai T, Okada T, Yoshiya I. Plasma lipid peroxides and alpha-tocopherol in critically ill patients. Crit Care Med 1984; 12: 957-9.
9. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986; 1: 11-4.
10. Seeger W, Ziegler A, Wolf HR. Serum alpha-tocopherol levels after high-dose enteral vitamin E administration in patients with acute respiratory failure. Intensive Care Med 1987; 13: 395-400.
11. Poli G, Biasi F, Chiarpotto E, Dianzani MU, De Luca A, Esterbauer H. Lipid peroxidation in human diseases: Evidence of red cell oxidative stress after circulatory shock. Free Radic Biol Med 1989; 6: 167-70.
12. Bertrand Y, Pincemail J, Hanique G, Denis B, Leenaerts L, Vankeerberghen L, et al. Differences in tocopherol-lipid ratios in ARDS and non-ARDS patients. Intensive Care Med 1989; 15: 87-93.
13. Machiedo GW, Powell RJ, Rush Jr BF, Swislocki NI, Dikdan G. The incidence of decreased red blood cell deformability in sepsis and the association with oxygen free radical damage and multiple-system organ failure. Arch Surg 1989; 124: 1386-9.
14. Sznajder JI, Fraiman A, Hall JB, Sanders W, Schmidt G, Crawford G, et al. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 1989; 96: 606-12.
15. Richard C, Lemonnier F, Thibault M, Couturier M, Auzepy P. Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome. Crit Care Med 1990; 18: 4-9.
16. Cross CE, Forte T, Stocker R, Louie S, Yamamoto Y, Ames BN, et al. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med 1990; 115: 396-404.
17. Pacht ER, Timerman AP, Lykens MG, Merola AJ. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991; 100: 1397-403.
18. Ogilvie AC, Groeneveld AB, Straub JP, Thijs LG. Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med 1991; 17: 40-4.
19. Keen RR, Stella L, Flanigan DP, Lands WE. Differential detection of plasma hydroperoxides in sepsis. Crit Care Med 1991; 19: 1114-9.
20. Leff JA, Parsons PE, Day CE, Moore EE, Moore FA, Oppegard MA, et al. Increased serum catalase activity in septic patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1992; 146: 985-9.
21. Leff JA, Parsons PE, Day CE, Taniguchi N, Jochum M, Fritz H, et al. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 1993; 341: 777-80.
22. Bunnell E, Pacht ER. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148: 1174-8.
23. Biasi F, Chiarpotto E, Lanfranco G, Capra A, Zummo U, Chiappino I, et al. Oxidative stress in the development of human ischemic hepatitis during circulatory shock. Free Radic Biol Med 1994; 17: 225-33.
24. Mathru M, Rooney MW, Dries DJ, Hirsch LJ, Barnes L, Tobin MJ. Urine hydrogen peroxide during adult respiratory distress syndrome in patients with and without sepsis. Chest 1994; 105: 232-6.
25. Ben Baouali A, Aube H, Maupoil V, Blettery B, Rochette L. Plasma lipid peroxidation in critically ill patients: Importance of mechanical ventilation. Free Radic Biol Med 1994; 16: 223-7.
26. Quinlan GJ, Evans TW, Gutteridge JM. Oxidative damage to plasma proteins in adult respiratory distress syndrome. Free Radic Res 1994; 20: 289-98.
27. Quinlan GJ, Evans TW, Gutteridge JM. 4-Hydroxy-2-nonenal levels increase in the plasma of patients with adult respiratory distress syndrome as linoleic acid appears to fall. Free Radic Res 1994; 21: 95-106.
28. Gutteridge JM, Quinlan GJ, Mumby S, Heath A, Evans TW. Primary plasma antioxidants in adult respiratory distress syndrome patients: Changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins. J Lab Clin Med 1994; 124: 263-73.
29. Goode HF, Howdle PD, Walker BE, Webster NR. Nitric oxide synthase activity is increased in patients with sepsis syndrome. Clin Sci (Colch) 1995; 88: 131-3.
30. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23: 646-51.
31. Galley HF, Davies MJ, Webster NR. Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 1996; 24: 1649-53.
32. Borrelli E, Roux-Lombard P, Grau GE, Girardin E, Ricou B, Dayer J, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24: 392-7.
33. Schorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH, Sanderson MJ, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996; 63: 760-5.
34. Galley HF, Webster NR. Elevated serum bleomycin-detectable iron concentrations in patients with sepsis syndrome. Intensive Care Med 1996; 22: 226-9.
35. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: A comparison of survivors and nonsurvivors. Crit Care Med 1996; 24: 1179-83.
36. Quinlan GJ, Lamb NJ, Tilley R, Evans TW, Gutteridge JM. Plasma hypoxanthine levels in ARDS: Implications for oxidative stress, morbidity, and mortality. Am J Respir Crit Care Med 1997; 155: 479-84.
37. Kretzschmar M, Pfeiffer L, Schmidt C, Schirrmeister W. Plasma levels of glutathione, alpha-tocopherol and lipid peroxides in polytraumatized patients; evidence for a stimulating effect of TNF alpha on glutathione synthesis. Exp Toxicol Pathol 1998; 50: 477-83.
38. Alonso de Vega JM, Diaz J, Serrano E, Carbonell LF. Plasma redox status relates to severity in critically ill patients. Crit Care Med 2000; 28: 1812-4.
39. Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med 1998; 26: 1536-44.
40. Metnitz PG, Bartens C, Fischer M, Fridrich P, Steltzer H, Druml W. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 1999; 25: 180-5.
41. Story DA, Ronco C, Bellomo R. Trace element and vitamin concentrations and losses in critically ill patients treated with continuous venovenous hemofiltration. Crit Care Med 1999; 27: 220-3.
42. Cook JA, DiLuzio NR. Protective effect of cysteine and methyl-prednisolone in lead acetate-endotoxin induced shock. Exp Mol Pathol 1973; 19: 127-38.
43. Heflin Jr AC, Brigham KL. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 1981; 68: 1253-60.
44. Ogawa R, Morita T, Kunimoto F, Fujita T. Changes in hepatic lipoperoxide concentration in endotoxemic rats. Circ Shock 1982; 9: 369-74.
45. Pekkanen T, Lindberg P, Sankari S. The effect of pretreatment with vitamin E on the effects of endotoxin in rat. Acta Pharmacol Toxicol (Copenh) 1983; 53: 64-9.
46. Bernard GR, Lucht WD, Niedermeyer ME, Snapper JR, Ogletree ML, Brigham KL. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest 1984; 73: 1772-84.
47. McKechnie K, Furman BL, Parratt JR. Modification by oxygen free radical scavengers of the metabolic and cardiovascular effects of endotoxin infusion in conscious rats. Circ Shock 1986; 19: 429-39.
48. Sugino K, Dohi K, Yamada K, Kawasaki T. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery 1987; 101: 746-52.
49. Kunimoto F, Morita T, Ogawa R, Fujita T. Inhibition of lipid peroxidation improves survival rate of endotoxemic rats. Circ Shock 1987; 21: 15-22.
50. Modig J, Sandin R. Haematological, physiological and survival data in a porcine model of adult respiratory distress syndrome induced by endotoxaemia. Effects of treatment with N-acetylcysteine. Acta Chir Scand 1988; 154: 169-77.
51. Broner CW, Shenep JL, Stidham GL, Stokes DC, Hildner WK. Effect of scavengers of oxygen-derived free radicals on mortality in endotoxin-challenged mice. Crit Care Med 1988; 16: 848-51.
52. Morgan RA, Manning PB, Coran AG, Drongowski RA, Till GO, Ward PD, et al. Oxygen free radical activity during live E. coli septic shock in the dog. Circ Shock 1988; 25: 319-23.
53. Bitterman H, Aoki N, Lefer AM. Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion shock. Proc Soc Exp Biol Med 1988; 188: 265-71.
54. Marinkovic D, Zuyderhoudt FM. Plasma lipid peroxides in murine sepsis-sex differences and effect of antioxidative/anti-inflammatory therapy. Free Radic Res Commun 1988; 4: 237-42.
55. Broner CW, Shenep JL, Stidham GL, Stokes DC, Fairclough D, Schonbaum GR, et al. Effect of antioxidants in experimental Escherichia coli septicemia. Circ Shock 1989; 29: 77-92.
56. Brackett DJ, Lerner MR, Wilson MF. Dimethyl sulfoxide antagonizes hypotensive, metabolic, and pathologic responses induced by endotoxin. Circ Shock 1991; 33: 156-63.
57. Peck MD, Alexander JW. Survival in septic guinea pigs is influenced by vitamin E, but not by vitamin C in enteral diets. J Parenter Enteral Nutr 1991; 15: 433-6.
58. Powell RJ, Machiedo GW, Rush Jr BF, Dikdan GS. Effect of oxygen-free radical scavengers on survival in sepsis. Am Surg 1991; 57: 86-8.
59. Novelli GP. Oxygen radicals in experimental shock: Effects of spin-trapping nitrones in ameliorating shock pathophysiology. Crit Care Med 1992; 20: 499-507.
60. Bakker J, Zhang H, Depierreux M, van Asbeck S, Vincent JL. Effects of N-acetylcysteine in endotoxic shock. J Crit Care 1994; 9: 236-43.
61. Zhang H, Spapen H, Nguyen DN, Benlabed M, Buurman WA, Vincent JL. Protective effects of N-acetyl-L-cysteine in endotoxemia. Am J Physiol 1994; 266: H1746-54.
62. Moch D, Schroppel B, Schoenberg MH, Schulz HJ, Thorab FC, Marzinzag M, et al. Protective effects of hydroxyethyl starch-deferoxamine in early sepsis. Shock 1995; 4: 425-32.
63. Villa P, Ghezzi P. Effect of N-acetyl-L-cysteine on sepsis in mice. Eur J Pharmacol 1995; 292: 341-4.
64. Suntres ZE, Shek PN. Treatment of LPS-induced tissue injury: Role of liposomal antioxidants. Shock 1996; 6 (Suppl 1): S57-64.
65. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 1996; 157: 1630-7.
66. Schmidt H, Schmidt W, Muller T, Bohrer H, Gebhard mm, Martin E. N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. Crit Care Med 1997; 25: 858-63.
67. Lauzurica P, Martinez-Martinez S, Marazuela M, Gomez del Arco P, Martinez C, Sanchez-Madrid F, et al. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-alpha. Eur J Immunol 1999; 29: 1890-900.
68. Bernard GR. Potential of N-acetylcysteine as treatment for the adult respiratory distress syndrome. Eur Respir J 1990; 11 (Suppl): 496s-8s.
69. Jepsen S, Herlevsen P, Knudsen P, Bud MI, Klausen NO. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo-controlled study. Crit Care Med 1992; 20: 918-23.
70. Suter PM, Domenighetti G, Schaller MD, Laverriere MC, Ritz R, Perret C. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest 1994; 105: 190-4.
71. Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, et al. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double-blind study. Crit Care Med 1994; 22: 1738-46.
72. Peake SL, Moran JL, Leppard PI. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 1996; 24: 1302-10.
73. Galley HF, Howdle PD, Walker BE, Webster NR. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med 1997; 23: 768-74.
74. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest 1997; 112: 164-72.
75. Berger MM, Spertini F, Shenkin A, Wardle C, Wiesner L, Schindler C, et al. Trace element supplementation modulates pulmonary infection rates after major burns: A double-blind placebo-controlled trial. Am J Clin Nutr 1998; 68: 365-71.
76. Heller AR, Groth G, Heller SC, Breitkreutz R, Nebe T, Quintel M, et al. N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients. Crit Care Med 2001; 29: 272-6.
77. Molnar Z, MacKinnon KL, Shearer E, Lowe D, Watson ID. The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients. Intensive Care Med 1998; 24: 230-5.
78. Preiser JC, Van Gossum A, Berre J, Vincent JL, Carpentier Y. Enteral feeding with a solution enriched with antioxidant vitamins A. C, and E enhances the resistance to oxidative stress. Crit Care Med 2000; 28: 3828-32.
79. Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 1999; 27: 1807-13.
80. Stapleton PP, O'Flaherty L, Redmond HP, Bouchier-Hayes DJ. Host defense - A role for the amino acid taurine? J Parenter Enteral Nutr 1998; 22: 42-8.